TY  - CHAP
M1  - Book, Section
TI  - Techniques for Staging and Restaging of Lung Cancer
A1  - Hong, Edward
A1  - Liptay, Michael J.
A2  - Sugarbaker, David J.
A2  - Bueno, Raphael
A2  - Colson, Yolonda L.
A2  - Jaklitsch, Michael T.
A2  - Krasna, Mark J.
A2  - Mentzer, Steven J.
A2  - Williams, Marcia
A2  - Adams, Ann
PY  - 2015
T2  - Adult Chest Surgery, 2e
AB  - Lung  cancer  is  the  leading  cause  of  cancer  death  in  the  United  States  in  both  men  and  women.  In  2011,  there  were  an  estimated  221,000  new  cases  of  lung  cancer  and  156,900  estimated  deaths  owing  to  the  disease.1  When  indicated,  surgery  is  the  most  effective  curative  therapy  for  lung  cancer.  For  patients  with  limited  non–small-cell  lung  cancer  (NSCLC),  lung  resection  remains  the  therapy  of  choice,  offering  the  greatest  potential  for  cure  and  long-term  survival.  Surgery  also  may  play  a  limited  role  in  small-cell  lung  cancer.  However,  of  patients  who  present  initially  with  lung  cancer,  55%  have  distant  metastatic  disease,  30%  have  disease  spread  to  regional  lymph  nodes,  and  only  15%  have  disease  confined  to  the  lung.2  Thus,  accurate  staging  in  lung  cancer  is  an  essential  component  of  management  and  prognosis.  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/23
UR  - accesssurgery.mhmedical.com/content.aspx?aid=1105842102
ER  -